| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | RBMY, a novel inhibitor of glycogen synthase kinase 3beta, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. | Chua, HH; Tsuei, DJ; Lee, PH; Jeng, YM; Lu, J; Wu, JF; Su, DS; Chen, YH; Chien, CS; Kao, PC; Lee, CN; Hu, RH; Ni, YH; Chang, MH | Hepatology 62(5), 1480-1496 |
